Q4 2025 Revenue: Decreased by $8.3 million to $50.3 million quarter-over-quarter. Full-Year 2025 Revenue: Decreased by 4% to $203 million year-over-year. Q4 2025 Net Loss: Increased by $0.3 million to ...
Experts say biology is becoming programmable, demanding faster research-to-market timelines India’s pharmaceutical sector must accelerate research-to-market timelines, strengthen clinical trial ...
The government has received nearly 200 applications for empanelling second-level fund managers under the research, development, and innovation (RDI) fund.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results